Cell Based Assays Market Report 2026

Cell Based Assays Market Overview

• Cell Based Assays market size has reached to $29.41 billion in 2025 • Expected to grow to $54.79 billion in 2030 at a compound annual growth rate (CAGR) of 13.3% • Growth Driver: Rise In Biologics Sales Is Anticipated To Fuel Cell-Based Assays Market • Market Trend: Advanced Platform For Accelerating Drug Discovery • North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under Cell Based Assays Market?

Cell-based assays are experimental tools that are designed to study reactions taking place inside the cells. These assays are used to study a mechanism or process of cellular function. The main products and services for cell-based assays are consumables, instruments, services, and software. Consumables are products that are used up or depleted during their use. The various instruments used are microplates, microplate readers, high throughput screening systems, and liquid handling systems. Different consumables include reagents and media, cells and cell lines, probes, and labels. The several technology types of cell-based assays are automated handling, flow cytometry, label-free detection, high-throughput screening, and others, and they are applied for drug discovery, basic research, ADME studies, predictive toxicology, and other purposes. The different end users include pharmaceutical and biotechnology companies, academic and government research institutes, contract research organizations (CROs), and others.

What Is The Cell Based Assays Market Growth Forecast?

The cell based assays market size is expected to see rapid growth in the next few years. It will grow to $54.79 billion in 2030 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to increasing adoption of AI-assisted assay analysis, rising demand for complex disease modeling, expansion of personalized medicine research, growing use of automation in laboratories, increasing investments in advanced screening platforms. Major trends in the forecast period include increasing adoption of high-throughput cell-based screening, rising use of automated cell handling systems, growing demand for predictive toxicology assays, expansion of label-free cell analysis methods, enhanced focus on physiologically relevant cell models.

Global Cell Based Assays Market Segmentation

1) By Product And Service: Consumables, Instruments, Services, Software 2) By Technology: Automated Handling, Flow Cytometry, Label-Free Detection, High-Throughput Screening, Other Technologies 3) By Application: Drug Discovery, Basic Research, Adme Studies, Predictive Toxicology, Other Applications 4) By End User: Pharmaceutical And Biotechnology Companies, Academic And Government Research Institutes, Contract Research Organizations (CRO), Other End Users Subsegments: 1) By Consumables: Cell Culture Media, Reagents And Kits, Cell Lines, Microplates 2) By Instruments: Microplate Readers, Flow Cytometers, Cell Imaging Systems, Automated Cell Culture Systems 3) By Services: Custom Assay Development, Contract Research Services 4) By Software: Data Analysis Software, Lab Management Software, Simulation And Modeling Software

What Is The Driver Of The Cell Based Assays Market?

The rise in biologics sales is expected to propel the cell-based assays market. Biologics, or biological products refers to medicines derived from living organisms, including a variety of products such as vaccines, blood and blood components, allergenics, somatic cells, gene therapies, tissues, and recombinant therapeutic proteins. Cell-based assays are pivotal in biologics for evaluating functionality, potency, safety, and bio-similarity. For instance, in October 2024, according to the Generics and Biosimilars Initiative, a Belgium-based organization, that provides high-quality, scientific information on generic and biosimilar medicines, beyond the nine leading biologics, two additional complex drugs recorded significant sales in 2023. Novo Nordisk’s Ozempic (semaglutide) and Eli Lilly’s Trulicity (dulaglutide), both prescribed for type 2 diabetes, achieved sales of US$14 billion and US$7.2 billion, respectively. Therefore, the rise in electronic payment methods is driving the cell-based assays market.

Key Players In The Global Cell Based Assays Market

Major companies operating in the cell based assays market are Promega Corporation, Bio-Rad Laboratories Inc, PerkinElmer Inc, Abcam plc, Enzo Life Sciences Inc, Cell Signaling Technology Inc, Cisbio International LLC, Eurofins Scientific SE, Charles River Laboratories International Inc, Miltenyi Biotec GmbH, Lonza Group Ltd, Corning Incorporated, Becton Dickinson and Company, Danaher Corporation, GE HealthCare Technologies Inc, BioVision Inc, Biotium Inc, ProQinase GmbH, QGel SA, Cell Biolabs Inc

Global Cell Based Assays Market Trends and Insights

Major companies operating in the cell-based assays market are launching new platforms based on technology such as cell-based phenotypic assay platforms to offer advanced solutions for drug discovery. A cell-based phenotypic assay platform is a system used in drug discovery that assesses cellular responses to compound treatments by integrating advanced imaging and analytical tools, empowered by artificial intelligence. For instance, in June 2024, Sphere Fluidics, a UK-based life sciences R&D company, launched Cyto-Cellect PLUS. Cyto-Cellect PLUS is a user-friendly Fluorescence Resonance Energy Transfer (FRET) assay that allows researchers to accurately measure IgG productivity with high sensitivity. Building on Sphere Fluidics’ original Cyto-Cellect Human IgGκ Detection Kit, this enhanced version also detects both IgG κ and λ light chains, broadening its applicability. The assay is fully compatible with existing Cyto-Mine® functionality, facilitating single-cell dispensing into 96-well and 384-well plates. Additionally, it meets relevant regulatory standards by being free of animal origins, making it easy to integrate into current cell line development processes.

What Are Latest Mergers And Acquisitions In The Cell Based Assays Market?

In April 2023, Discovery Life Sciences, a US-based provider of biospecimen solutions and services, acquired ReachBio Research Labs for an undisclosed amount. With this acquisition, Discovery Life Sciences aims to expand its preclinical and clinical research capabilities, enhance its biologics testing services, accelerate drug development timelines, and strengthen its overall service portfolio. ReachBio Research Labs is a US-based contract research organization (CRO) that provides cell based assays.

Regional Outlook

North America was the largest region in the cell-based assays market in 2025. Western Europe was the second largest region in the global cell-based assays market share. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cell Based Assays Market?

The cell-based assay market consists of sales of reagents, cell lines, microplates, microplates, assay kits, probes, and labels. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cell Based Assays Market Report 2026?

The cell based assays market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cell based assays industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.